Like Adheris, Inc.

closed 3/1/2006 via PR Newswire

Ventiv Health, acquired Adheris, Inc.

synopsis: Ventiv Health, Inc. announced the completion of its acquisition of Adheris, Inc., the industry leader in the area of patient compliance and persistency programs. Ventiv announced on February 3 that it had acquired Adheris for $60 million in cash and stock, plus earn-out payments for exceeding specified financial targets.
buyer: Ventiv Health
inVentiv Health, Inc. is the leading provider of commercialization and complementary services to the global pharmaceutical, life sciences and biotechnology industries. inVentiv delivers its customized clinical, sales, marketing and communications solutions. "
target: Adheris, Inc.
Adheris, Inc. is the leading provider of patient adherence programs in the U.S. Through its expansive retail pharmacy network of over 20,000 stores and proprietary technology, Adheris has developed a strong market position in the battle against patient pharmaceutical non-compliance.
price ($mm)
$60
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 7/26/2022 via BNC Analysis

MedAdvisor Limited, will acquire GuildLink

synopsis: MedAdvisor, a medication management platform, will acquire GuildLink from Guild Group, a business dedicated to protecting Australian professionals. GuildLink is a provider of healthcare solutions in Australia. They offer a cloud platform that helps pharmacists to manage their business. They also operate a data warehouse for medicines information.
buyer: MedAdvisor Limited (ASX:MDR:$26.91)
MedAdvisor is a world class medication management platform focused on addressing the gap and burden of medication adherence. The highly automated Australian software system connects patients to their local pharmacy, providing them with real time access to their personal medication records. "
target parent: The Pharmacy Guild of Australia
target: GuildLink
GuildLink is a provider of digital healthcare solutions and medicines information in Australia. GuildLink offers a cloud-based platform that helps pharmacists to better manage their business and improve patient outcomes. They also operate a secure data warehouse for medicines information.
price ($mm)
$6.35
rev ($mm)
$5
EBITDA ($mm)
EV / rev
1.2x
EV / EBITDA
closed 1/5/2022 via Company Press Release

Omnicell, Inc., acquired MarkeTouch Media, Inc.

synopsis: Omnicell, Inc., a leading provider of medication management solutions and adherence tools for health systems and pharmacies, announced it has acquired pharmacy software solutions provider MarkeTouch Media, LLC. MarkeTouch Media is the preeminent provider of pharmacy prescription management and patient engagement solutions.
buyer: Omnicell, Inc. (OMCL:$914.37)
Omnicell provides medication management solutions and adherence tools for health systems and pharmacies. Omnicell more efficient ways to manage medication through the Autonomous Pharmacy, a combination of automation, intelligence, and technology-enabled services, powered by a cloud data platform. "
target: MarkeTouch Media, Inc.
MarkeTouch Media is the preeminent provider of pharmacy prescription management and patient engagement solutions which significantly improve medication adherence and health outcomes for patients, while increasing revenue, profitability, efficiency, and customer loyalty for pharmacies.
price ($mm)
$82
rev ($mm)
$14
EBITDA ($mm)
EV / rev
5.9x
EV / EBITDA
closed 12/15/2021 via BusinessWire

XIFIN, Inc., acquired OmniSYS, LLC

synopsis: XIFIN has acquired OmniSYS, a leading provider of technology solutions for the retail pharmacy industry. The acquisition further expands on XIFIN’s role as a top provider of solutions and services that streamline and optimize the billing and claims process, provide healthcare leaders with greater business visibility, and support patient engagement.
buyer parent: Avista Capital Partners
buyer: XIFIN, Inc.
XIFIN is a healthcare information technology company that leverages diagnostic information to improve the quality and economics of healthcare. The company's cloud-based technology facilitates connectivity and workflow automation for accessing and sharing clinical and financial diagnostic data. "
target parent: NexPhase Capital
target: OmniSYS, LLC
OmniSYS is a leading provider of medical claims management, compliance, patient engagement, and pricing information technology software for retail pharmacies, hospital pharmacies, and pharmaceutical companies.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/18/2021 via BusinessWire

BlackRock, Inc., acquired Transaction Data Systems

synopsis: Transaction Data Systems (TDS), a leader in pharmacy software solutions and services, announced that BlackRock Long Term Private Capital (LTPC) has acquired a majority interest in the company. TDS’ previous owner, GTCR, will retain a minority interest.
buyer: BlackRock, Inc. (BLK:$19,374.00)
BlackRock is a global leader in investment management, risk management and advisory services for institutional & retail clients. BlackRock helps clients meet their goals with a range of products that include separate accounts, mutual funds, exchange-traded funds, & other pooled investment vehicles. "
target parent: GTCR, LLC
target: Transaction Data Systems
Transaction Data Systems (TDS), with its portfolio of products and services including Rx30, Computer-Rx, Enhanced Medication Services, and Pharm Assess, provides pharmacy management systems and innovative technology solutions to the pharmacy industry.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/1/2020 via BusinessWire

Francisco Partners Management LLC, acquired Smith Technologies

synopsis: Francisco Partners has acquired Smith Technologies, a subsidiary of J M Smith Corporation. Smith Technologies® is comprised of products and services from the QS/1, Integra, LTC and PUBLIQ Software brands. QS/1 designs, builds, and supports industry-leading retail pharmacy management systems. The company will be rebranded as RedSail Technologies
buyer: Francisco Partners Management LLC
Francisco Partners is a leading global private equity firm that specializes in investments in technology and technology-enabled businesses. They have invested in over 275 technology companies, making them one of the most active and longstanding investors in the technology industry. "
target parent: J M Smith Corporation
target: Smith Technologies
Smith Technologies, a unit J M Smith Corporation, is comprised of products and services from the QS/1, Integra, LTC and PUBLIQ Software brands. QS/1 designs, builds, and supports industry-leading retail pharmacy management systems. PUBLIQ Software provides software for state and local governments.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/9/2019 via Company Press Release

Cardinal Health, Inc., acquired Mirixa Corporation

synopsis: Cardinal Health, Inc., a global, integrated healthcare services and products company, announced it has acquired Mirixa Corporation, a leading provider of technology-enabled solutions for the provision of medication therapy management (MTM) services, from the National Community Pharmacists Association (NCPA).
buyer: Cardinal Health, Inc. (CAH:$141,935.00)
Cardinal Health, Inc. is a global, integrated healthcare services and products company. The company provides clinically proven medical products, pharmaceuticals and cost-effective solutions that enhance supply chain efficiency from hospital to home. "
target parent: National Community Pharmacists Association
target: Mirixa Corporation
Mirixa Corporation is a leading healthcare technology and services company. They identify and connect patients with trusted pharmacists and other healthcare providers for individualized medication counseling. Their innovative technology and services improve patients' health and reduce costs.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/31/2017 via BNC Analysis

TELUS Corporation, acquired Kroll Computer Systems Inc.

synopsis: TELUS Corporation acquired Kroll Computer Systems Inc, a provider pharmacy software solutions, based in Canada. Kroll is the most efficient, innovative and user-friendly pharmacy management software available on the market today, backed by over 32 years of experience and customer satisfaction.
buyer: TELUS Corporation (TU:$17,072.00)
TELUS Corporation is Canada's fastest-growing national telecommunications company. It provides a wide range of communications products and services, including wireless, data, Internet protocol (IP), voice, television, entertainment and video, and is Canada's largest healthcare IT provider. "
target: Kroll Computer Systems Inc.
Kroll Computer Systems' suite of pharmacy specific applications provides software solutions to fulfill all of a pharmacy’s requirements today and beyond. Kroll is the most efficient, innovative and user-friendly pharmacy management software available on the market today.
price ($mm)
$250
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/14/2016 via Company Press Release

Omnicell, Inc., acquired Ateb, Inc.

synopsis: Omnicell, Inc., a leading provider of medication and supply management solutions and adherence tools to healthcare systems and pharmacies, announced the completed acquisition of Ateb, Inc. Ateb is the leading provider of pharmacy-based patient care solutions and medication synchronization.
buyer: Omnicell, Inc. (OMCL:$914.37)
Since 1992, Omnicell has been creating innovative solutions to improve patient care, anywhere it is delivered. Omnicell is a leading supplier of comprehensive automation and business analytics software for medication and supply management across the entire health care continuum. "
target: Ateb, Inc.
Ateb is the industry’s leading provider of pharmacy-based patient care solutions and the medication synchronization solutions leader to independent and chain pharmacies. Ateb’s innovative patient engagement solutions enable pharmacists to provide a higher standard of affordable patient care.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/6/2016 via PR Newswire

Computer-Rx merged with Rx30 Pharmacy System,

synopsis: Rx30, a leading developer and supplier of pharmacy management software solutions to the independent retail, hospital, long-term care and specialty pharmacy markets, announced that it has combined with Computer-Rx, an innovative pharmacy software platform also focused on community pharmacies.
buyer: Rx30 Pharmacy System
Rx30 is a total Pharmacy Management Software application that truly acts as the hub for all pharmacy management activities, including prescription dispensing, fully automated refills and reminders, workflow management, adherence management, document management, smart phone/web refills and more. "
target: Computer-Rx
Computer-Rx is one of the most consistently growing pharmacy software vendors in the U.S. with over thirty years of experience and more than two thousand customers in 47 states. They provide proven Pharmacy Management Software and Services that promote growth and efficiency to community pharmacy.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/4/2014 via Company Press Release

CompuGroup Medical AG, acquired farma3tec S.r.l.

synopsis: CompuGroup Medical AG (CGM), a leading eHealth company worldwide, concluded a transaction to acquire farma3tec S.r.l., a subsidiary of Alliance Healthcare Italia, and a leading software provider in the Pharmacy Information Systems Sector.
buyer: CompuGroup Medical AG (DB:COP:$1,158.07)
CompuGroup Medical (CGM) is one of the leading eHealth companies worldwide. Its software products are designed to support medical and organizational activities, its information services for the healthcare system and its web-based personal health records contribute towards more efficient healthcare. "
target parent: Alliance Healthcare Italia S.p.A.
target: farma3tec S.r.l.
farma3tec develops software solutions for pharmacies in Italy, with over 5,000 customers. Additionally, it sells hardware and other products.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/17/2012 via Market Wire

Logibec Groupe Informatique, Ltd., acquired Artefact Informatique, Inc.

synopsis: Logibec Groupe Informatique announced it has acquired Artefact Informatique, Inc. Artefact is a leading provider of clinical software solutions for healthcare organizations. Artefact is based in Quebec City, Canada and has many of Quebec's largest healthcare organizations using its software solutions.
buyer parent: OMERS Private Equity
buyer: Logibec Groupe Informatique, Ltd.
Logibec is among the fastest-growing North American companies specializing in the development, marketing, implementation and support of information systems for the health and social services sector. "
target parent: IBM
target: Artefact Informatique, Inc.
Artefact is a leading provider of clinical software solutions for healthcare organizations. Artefact has established a prominent position in Radiology and Pharmacy Information Management Systems and clinical data interchange, both locally and for networked systems (Health Information Interchange).
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 5/12/2009 via Market Wire

HealthScreen Solutions Inc., will acquire Regent Healthcare Systems, Inc

synopsis: Healthscreen Solutions Inc. the premier supplier of physician practice enhancing services and electronic medical record (EMR) software to the Canadian market, announced that it has signed a definitive agreement to acquire all the shares outstanding of New Westminster, BC-based Regent Healthcare Systems.
buyer: HealthScreen Solutions Inc.
Healthscreen is a Canadian health care company dedicated to assisting Canadian physicians with innovative services and software that enhance their practices and increase the level of care offered to patients. "
target: Regent Healthcare Systems, Inc
Since 1988, Regent Healthcare Systems has been a leader in providing premium Medical Practice Management software and services to meet the growing demands of busy medical practitioners and their staff.
price ($mm)[EV]
$0.86 [$0.75]
rev ($mm)
$1
EBITDA ($mm)
$0
EV / rev
1.7x
EV / EBITDA
5.3x
closed 11/21/2008 via Market Wire

Mediware Information Systems Inc., acquired Hann's On Software

synopsis: Mediware Information Systems, Inc. announced that it has acquired substantially all the assets of Hann's On Software (HOS), a pharmacy management software provider. Mediware's purchase agreement includes a cash payment of approximately $3.5M, with an additional earn out opportunity based on operational performance.
buyer: Mediware Information Systems Inc.
Mediware delivers ClosedLoop blood and medication management software systems that encapsulate information supporting patient therapies, reinforce patient safety practices and improve efficiencies to lower costs. "
target: Hann's On Software
Hann's On Software is a provider of software and services that address the needs of the pharmacies in small hospitals, behavioral health facilities, and the expanding alternate-site/home infusion and specialty pharmacy markets.
price ($mm)
$3.46
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/12/2007 via BusinessWire

Arcadia Resources, Inc., acquired JASCORP

synopsis: Arcadia Resources, Inc. an innovator in consumer health care services, has acquired the JASCORP pharmacy management software subsidiary of The F. Dohmen Co., a family-owned business based in Germantown, Wisconsin.
buyer: Arcadia Resources, Inc. (KAD:$103.60)
Arcadia Resources, Inc. is a national provider of alternate site healthcare services and products, including respiratory and durable medical equipment; non-medical and medical staffing, including travel nursing; comprehensive central fill and licensed pharmacy services. "
target parent: The F. Dohmen Co.
target: JASCORP
JASCORP has over 25 years of experience in offering outstanding retail pharmacy software and pharmaceutical management software systems that are easy to use and packed with useful features. JASRx.com is our award-winning website that allows your patients to request refills over the Internet.
price ($mm)
$2.05
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/19/2021 via BNC Analysis

Glintt, acquired FarmaTools

synopsis: Glintt, a leading consulting and technological services company based in Portugal, has acquired FarmaTools from Dominion Global, a global provider of multitechnology services. FarmaTools is a hospital pharmacy software solutions provider in Spain. Their software provides solutions for administrative management and clinical management.
buyer: Glintt (ENXTLS:GLINT:$108.88)
Glintt is a leading consulting and technological services company based in Portugal. Glintt develops products for hospitals, clinics and pharmacies. They support their clients in their digital transformation and offers software solutions that helps them to run their business more efficiently. "
target parent: Dominion Global
target: FarmaTools
FarmaTools is a pharmacy software solutions provider in Spain. FarmaTools offers an innovative, effective, and automated system for hospital pharmacies. Their software provides solutions for administrative management and clinical management.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 12/18/2019 via GlobeNewswire

Akerna, will acquire Ample Organics Inc.

synopsis: Akerna, a global regulatory compliance technology company in the cannabis space, will be acquiring Ample Organics, a Canadian software company building technology to support cannabis businesses. Ample Organics is developing tools that foster transparency and facilitate compliance.
buyer: Akerna (KERN:$13.09)
Akerna is a global regulatory compliance technology company in the cannabis space. Akerna’s service offerings include the MJ Platform, its leading seed-to-sale, regulatory compliance, technology solution, and Leaf Data Systems, which provide government clients with compliance technology solutions. "
target: Ample Organics Inc.
Ample Organics is a software company building technology to support cannabis businesses. They're developing tools that foster transparency, facilitate compliance, and build trust between cannabis licence holders, government bodies, and the public.
price ($mm)
$38
rev ($mm)
$5
EBITDA ($mm)
EV / rev
9.3x
EV / EBITDA
closed 10/31/2017 via PR Newswire

Clinical Support Services merged with Medicine-On-Time, LLC,

synopsis: Medicine-On-Time, LLC and Clinical Support Services (CSS) announced the formation of Star MTM, LLC, into which CSS's business will be merged. CSS is a national leader in medication therapy management and drug-related quality improvement programs, assisting healthcare organizations in successfully reaching clinical and quality goals.
buyer: Medicine-On-Time, LLC
Medicine-On-Time is a leader in the medication adherence market, pioneering innovations in our flagship multi-dose compliance packaging and software solution, as well as offering a growing array of medication management and adherence products and services. "
target: Clinical Support Services
Clinical Support Services (CSS) is a national leader in medication therapy management and drug-related quality improvement programs, assisting healthcare organizations in successfully reaching clinical and quality goals. CSS's clients include Medicare, Medicaid, and pharmacy organizations.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/28/2017 via GlobeNewswire

Pharmagest Interactive S.A., acquired CareMeds Ltd

synopsis: Pharmagest, the French leader in pharmacy information technology, has acquired CareMeds, a company that developed a secure cloud-based traceability platform to track the medication cycle using pill dispensers.
buyer: Pharmagest Interactive S.A. (ENXTPA:PHA:$199.39)
Pharmagest is the French leader in pharmacy information technology. Pharmagest has developed specialised businesses, including pharmacy IT, e-Health solutions, solutions for healthcare professionals, solutions for laboratories, connected health devices and apps, and a sales financing marketplace. "
target: CareMeds Ltd
CareMeds developed a secure cloud-based traceability platform to track the medication cycle using pill dispensers. These products provide pharmacists and elderly residential care homes with secure medication management batch traceability for prescription drugs prepared in pill dispensers.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/12/2012 via PR Newswire

Weedmaps, LLC, acquired MMJMenu, LLC

synopsis: General Cannabis, Inc., a technology-based Internet marketing services company, announced that its wholly-owned subsidiary, WeedMaps Media, Inc., has signed documents to acquire the assets of MMJMenu, LLC, the medical marijuana industry's leading provider of seed-to-sale collective management and point of sale software.
buyer parent: General Cannabis, Inc.
buyer: Weedmaps, LLC (MAPS:$178.91)
WeedMaps.com is a community where medical marijuana patients connect with other patients in their geographic region to freely discuss and review local cannabis co-operatives, dispensaries, medical doctors and delivery services. Dispensaries list their services for free. "
target: MMJMenu, LLC
MMJMenu provides business management software for dispensaries and growers, enabling them to track their medical cannabis from seed to sale. MMJMenu.com is used by hundreds of medical marijuana businesses in California, Colorado, Michigan, Montana, Washington as well as in Canada.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/31/2013 via PR Newswire

Adheris, Inc., purchased Catalina Health from Catalina Marketing Corporation

synopsis: inVentiv Health, offering best-in-class clinical, commercial and consulting services, announced that it has acquired Catalina Health, and combined the organization with Adheris, an inVentiv Health company. Both Adheris and Catalina Health work through pharmacies across the country to deliver adherence communications to millions of people.
buyer parent: inVentiv Health, Inc.
buyer: Adheris, Inc.
Adheris, Inc. is the leading provider of patient adherence programs in the U.S. Through its expansive retail pharmacy network of over 20,000 stores and proprietary technology, Adheris has developed a strong market position in the battle against patient pharmaceutical non-compliance. "
seller parent: Hellman & Friedman LLC
seller: Catalina Marketing Corporation
Catalina Health Resource, LLC operates a personalized health media network in the United States. It delivers patient-driven educational support and information designed to empower patients to make better health care decisions.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/1/2006 via PR Newswire

Ventiv Health, acquired Adheris, Inc.

synopsis: Ventiv Health, Inc. announced the completion of its acquisition of Adheris, Inc., the industry leader in the area of patient compliance and persistency programs. Ventiv announced on February 3 that it had acquired Adheris for $60 million in cash and stock, plus earn-out payments for exceeding specified financial targets.
buyer: Ventiv Health
inVentiv Health, Inc. is the leading provider of commercialization and complementary services to the global pharmaceutical, life sciences and biotechnology industries. inVentiv delivers its customized clinical, sales, marketing and communications solutions. "
target: Adheris, Inc.
Adheris, Inc. is the leading provider of patient adherence programs in the U.S. Through its expansive retail pharmacy network of over 20,000 stores and proprietary technology, Adheris has developed a strong market position in the battle against patient pharmaceutical non-compliance.
price ($mm)
$60
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 5/10/2017 via BNC Analysis

inVentiv Health, Inc. will be merged with INC Research, Inc.,

synopsis: INC Research Holdings, Inc., a leading global Phase I-IV Contract Research Organization ("CRO"), and inVentiv Health, Inc., a leading, global CRO and Contract Commercial Organization will merge. INC Research shareholders will own approximately 53 percent and inVentiv shareholders will own approximately 47 percent of the merged entity.
buyer: INC Research, Inc. (INCR:$4,730.38)
INC Research is a leading global contract research organization ("CRO") providing the full range of Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. "
target parent: Thomas H. Lee Partners, L.P.
target: inVentiv Health, Inc.
inVentiv Health is a global professional services organization designed to help the biopharmaceutical industry accelerate the delivery of much-needed therapies to market. Their Clinical Research Organization (CRO) and Contract Commercial Organization (CCO) offer a differentiated suite of services.
price ($mm)[EV]
$2,453 [$4,552]
rev ($mm)
$2,156
EBITDA ($mm)
$306
EV / rev
2.1x
EV / EBITDA
14.9x
closed 10/31/2013 via PR Newswire

Adheris, Inc., purchased Catalina Health from Catalina Marketing Corporation

synopsis: inVentiv Health, offering best-in-class clinical, commercial and consulting services, announced that it has acquired Catalina Health, and combined the organization with Adheris, an inVentiv Health company. Both Adheris and Catalina Health work through pharmacies across the country to deliver adherence communications to millions of people.
buyer parent: inVentiv Health, Inc.
buyer: Adheris, Inc.
Adheris, Inc. is the leading provider of patient adherence programs in the U.S. Through its expansive retail pharmacy network of over 20,000 stores and proprietary technology, Adheris has developed a strong market position in the battle against patient pharmaceutical non-compliance. "
seller parent: Hellman & Friedman LLC
seller: Catalina Marketing Corporation
Catalina Health Resource, LLC operates a personalized health media network in the United States. It delivers patient-driven educational support and information designed to empower patients to make better health care decisions.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/3/2013 via BusinessWire

J. Knipper and Company, acquired MySTRO

synopsis: J. Knipper and Company, Inc. announced that it has acquired the inVentiv Health MySTRO Sample Management and Fulfillment business, including regulatory compliance, sample accountability, and fulfillment services. With this acquisition, the company becomes the largest end-to-end pharmaceutical samples management service provider in the U.S.
buyer: J. Knipper and Company
J. Knipper and Company, Inc., provides healthcare marketing solutions in direct marketing, sampling, compliance, information technology, and salesforce productivity. J. Knipper continues to offer innovative solutions to salesforce challenges, including MyPharmaRep.com and MySampleCloset.com. "
target parent: Thomas H. Lee Partners, L.P.
target: MySTRO
MySTRO is a leading provider of multi-channel marketing and sales force support solutions to clients in the pharmaceutical, healthcare and life-science industries. The company also offers complete outsourced sample accountability, regulatory and PDMA compliance services.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/5/2012 via PR Newswire

inVentiv Health, Inc., acquired Kazaam Interactive

synopsis: inVentiv Health, Inc., offering best-in-class clinical, commercial and consulting services to the healthcare industry, announced that it has acquired Kazaam Interactive, a full-service interactive agency providing comprehensive solutions and services for healthcare agencies and brands.
buyer parent: Thomas H. Lee Partners, L.P.
buyer: inVentiv Health, Inc.
inVentiv Health, Inc. is a leading global provider of best-in-class clinical, commercial and consulting services to companies seeking to accelerate performance. inVentiv's client roster includes more than 550 pharmaceutical, biotech and life sciences companies. "
target: Kazaam Interactive
Kazaam is a full-service digital marketing agency offering premier digital strategy and solutions to brands and organizations. The company has worked with over sixty of the world's largest brands and brings a real-world understanding for utilizing the online channels.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/3/2012 via PR Newswire

inVentiv Health, Inc., acquired Kforce Clinical Research, Inc.

synopsis: inVentiv Health, Inc., offering best-in-class clinical, commercial and consulting services to the healthcare industry, announced that it has completed the acquisition of Kforce Clinical Research, Inc., a provider of functional outsourcing solutions to pharmaceutical, biotech and medical device companies, from Kforce Inc. for $50 million in cash.
buyer parent: Thomas H. Lee Partners, L.P.
buyer: inVentiv Health, Inc.
inVentiv Health, Inc. is a leading global provider of best-in-class clinical, commercial and consulting services to companies seeking to accelerate performance. inVentiv's client roster includes more than 550 pharmaceutical, biotech and life sciences companies. "
target parent: Kforce Inc.
target: Kforce Clinical Research, Inc.
Kforce Clinical Research Inc. provides clinical trial resourcing solutions. The company offers outsourcing and contract staffing and permanent placement services. Kforce Clinical Research Inc. operates as a subsidiary of Kforce Inc.
price ($mm)
$50
rev ($mm)
$106
EBITDA ($mm)
EV / rev
0.5x
EV / EBITDA
closed 9/8/2010 via GlobeNewswire

inVentiv Health, Inc., acquired Star Terre Santé

synopsis: inVentiv Health, a provider of end-to-end clinical development, launch and commercialization services to the healthcare industry, announced that it has acquired Substrat'Homme SA, commonly known as Star Terre Santé. Star Terre Santé will provide advertising and promotional services to inVentiv Communications' clients in France and Benelux.
buyer parent: Thomas H. Lee Partners, L.P.
buyer: inVentiv Health, Inc.
inVentiv Health, Inc. is a leading, global provider of data-driven, outsourced solutions to the pharmaceutical, life sciences and healthcare industries. inVentiv's full suite of marketing, sales, clinical development and post-approval solutions drive speed and effectiveness. "
target: Star Terre Santé
Substrat'Homme SA, commonly known as Star Terre Santé, is a leading group of healthcare marketing and communications agencies based in Paris.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/4/2010 via GlobeNewswire

Thomas H. Lee Partners, L.P., acquired inVentiv Health, Inc.

synopsis: inVentiv Health, Inc., a leading provider of end-to-end clinical development, launch and commercialization services to the global pharmaceutical and healthcare industries, announced the completion of the acquisition of inVentiv Health, Inc. by Thomas H. Lee Partners, L.P.
buyer: Thomas H. Lee Partners, L.P.
Thomas H. Lee Partners, L.P. is one of the largest and oldest private equity investment firms in the United States and has raised and managed almost $20 billion of capital, making investments in over 100 businesses since its founding in 1974. "
target: inVentiv Health, Inc.
inVentiv Health, Inc. is the leading provider of commercialization and complementary services to the global pharmaceutical, life sciences and biotechnology industries. inVentiv delivers its customized clinical, sales, marketing and communications solutions through three core business segments.
price ($mm)[EV]
$911 [$1,175]
rev ($mm)
$1,084
EBITDA ($mm)
$137
EV / rev
1.1x
EV / EBITDA
8.7x
closed 6/26/2007 via BNC Analysis

inVentiv Health, Inc., acquired Innovative Health Strategies, Inc.

synopsis: inVentiv Health, Inc. announced that it has signed a definitive agreement to acquire Innovative Health Strategies, Inc. and the related AWAC.MD business (collectively "AWAC"), a leading provider of proprietary IT-driven cost containment and medical consulting solutions to third party administrators and insurance carriers.
buyer: inVentiv Health, Inc.
inVentiv Health, Inc. is the leading provider of commercialization and complementary services to the global pharmaceutical, life sciences and biotechnology industries. inVentiv delivers its customized clinical, sales, marketing and communications solutions. "
target: Innovative Health Strategies, Inc.
AWAC(R), Innovative Health Strategies' core proprietary software platform, utilizes over 60,000 unique algorithms applied to client provider claims, pharmacy data, pre-certification and related data to uncover opportunities for cost reductions.
price ($mm)
$75
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/1/2007 via PR Newswire

inVentiv Health, Inc., acquired Addison Whitney

synopsis: Addison Whitney, a full service brand identity and consulting firm that specializes in creating unique brand solutions for global pharmaceutical, biotechnology and medical companies, announces its acquisition by inVentiv Health.
buyer: inVentiv Health, Inc.
inVentiv Health, Inc. is the leading provider of commercialization and complementary services to the global pharmaceutical, life sciences and biotechnology industries. inVentiv delivers its customized clinical, sales, marketing and communications solutions. "
target: Addison Whitney
Addison Whitney is a full service brand identity consultancy. Addison Whitney Healthcare strives to provide powerful brand identity solutions to global pharmaceutical, biotechnology and medical companies.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/1/2007 via

inVentiv Health, Inc., acquired Ignite Health

synopsis: inVentiv Health, Inc. has signed a definitive agreement to acquire Ignite Health, an independent healthcare advertising agency that uses a technology-centric approach to communicate with people living with chronic diseases and those who care for them.
buyer: inVentiv Health, Inc.
inVentiv Health, Inc. is the leading provider of commercialization and complementary services to the global pharmaceutical, life sciences and biotechnology industries. inVentiv delivers its customized clinical, sales, marketing and communications solutions. "
target: Ignite Health
Ignite Health is a new breed of advertising agency with a fresh approach to healthcare marketing and communications. By complementing highly focused print strategies with a wide range of tailored electronic strategies the company helps clients meet their objectives effectively and efficiently.
price ($mm)
$20
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/7/2006 via PR Newswire

Inventiv Health, acquired Maxwell Group Inc.

synopsis: inVentiv Health, Inc. has completed the acquisition of The Maxwell Group, Inc. and its MedConference brand of services. MedConference, a pioneer in the field of on-line events, e-learning and web conferencing, was founded in 1989 and is a leading provider of live and on-demand virtual event services to the pharmaceutical industry.
buyer: Inventiv Health
inVentiv Health, Inc. is the leading provider of commercialization and complementary services to the global pharmaceutical, life sciences and biotechnology industries. inVentiv delivers its customized clinical, sales, marketing and communications solutions. "
target: Maxwell Group Inc.
Maxwell supports both live web events and on-demand events on most platforms in a variety of verticals. We deliver the highest quality turnkey web event services and support tools pre-event, live event and post event.
price ($mm)
$7.00
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/7/2006 via PR Newswire

Inventiv Health, acquired American Speaker Education Research and Training, LLC

synopsis: inVentiv Health, Inc. has completed the acquisition of American Speakers Education Research Training LLC (ASERT), a medical education and training company, and DialogCoach LLC, a specialty training organization that employs proprietary software tools and e-learning solutions to improve sales force effectiveness.
buyer: Inventiv Health
inVentiv Health, Inc. is the leading provider of commercialization and complementary services to the global pharmaceutical, life sciences and biotechnology industries. inVentiv delivers its customized clinical, sales, marketing and communications solutions. "
target: American Speaker Education Research and Training, LLC
ASERT LLC is a training company that specializes in the pharmaceutical, biotechnology and medical devices industries. DialogCoach LLC is a specialty training organization developed around a proprietary software, DialogCoach, and e-learning solutions to improve sales and call center effectiveness.
price ($mm)
$5.00
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/5/2006 via PR Newswire

Ventiv Health, acquired Synergos, Inc.

synopsis: inVentiv Health, Inc. announced the completion of its acquisitions of Synergos, Inc., a focused clinical services provider, and Jeffrey Simbrow Associates Inc., Canada's leading healthcare marketing and communications agency. Both acquisitions were announced by inVentiv on March 13.
buyer: Ventiv Health
inVentiv Health, Inc. is the leading provider of commercialization and complementary services to the global pharmaceutical, life sciences and biotechnology industries. inVentiv delivers its customized clinical, sales, marketing and communications solutions. "
target: Synergos, Inc.
Synergos, Inc. is a functional service provider specializing in clinical trials management services, particularly project management and monitoring as well as investigator and patient recruitment. Synergos also provides regulatory affairs and quality compliance services.
price ($mm)
$5.75
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/5/2006 via PR Newswire

Inchord Communications, Inc., acquired Jeffrey Simbrow Associates

synopsis: inVentiv Health, Inc. announced the completion of its acquisitions of Synergos, Inc., a focused clinical services provider, and Jeffrey Simbrow Associates Inc., Canada's leading healthcare marketing and communications agency. Both acquisitions were announced by inVentiv on March 13.
buyer parent: inVentiv Health, Inc.
buyer: Inchord Communications, Inc.
Westerville, Ohio-based inChord Communications is the largest privately held healthcare marketing organization in the world serving a broad range of clients including many of the world's top pharmaceutical companies. "
target: Jeffrey Simbrow Associates
Jeffrey Simbrow Associates is the largest healthcare- focused advertising and marketing agency in Canada and is internationally recognized for its expertise in marketing management training.
price ($mm)
$8.64
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/1/2006 via PR Newswire

Ventiv Health, acquired Adheris, Inc.

synopsis: Ventiv Health, Inc. announced the completion of its acquisition of Adheris, Inc., the industry leader in the area of patient compliance and persistency programs. Ventiv announced on February 3 that it had acquired Adheris for $60 million in cash and stock, plus earn-out payments for exceeding specified financial targets.
buyer: Ventiv Health
inVentiv Health, Inc. is the leading provider of commercialization and complementary services to the global pharmaceutical, life sciences and biotechnology industries. inVentiv delivers its customized clinical, sales, marketing and communications solutions. "
target: Adheris, Inc.
Adheris, Inc. is the leading provider of patient adherence programs in the U.S. Through its expansive retail pharmacy network of over 20,000 stores and proprietary technology, Adheris has developed a strong market position in the battle against patient pharmaceutical non-compliance.
price ($mm)
$60
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/6/2005 via PR Newswire

Ventiv Health, acquired Inchord Communications, Inc.

synopsis: Ventiv Health, Inc. announced the completion of its acquisition of inChord Communications, Inc., the world's largest independently-owned global healthcare marketing and communications company. Ventiv announced on September 7, 2005 that it would acquire inChord for $185 million in cash and stock, plus closing adjustments and earn-out payments.
buyer: Ventiv Health
inVentiv Health, Inc. is the leading provider of commercialization and complementary services to the global pharmaceutical, life sciences and biotechnology industries. inVentiv delivers its customized clinical, sales, marketing and communications solutions. "
target: Inchord Communications, Inc.
Westerville, Ohio-based inChord Communications is the largest privately held healthcare marketing organization in the world serving a broad range of clients including many of the world's top pharmaceutical companies.
price ($mm)
$184
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/22/2004 via PR Newswire

Ventiv Health, acquired HHI Clinical Research & Statistical Services, L.L.C.

synopsis: Ventiv Health, Inc. VTIV, a leading provider of late-stage clinical, sales, marketing and compliance services to pharmaceutical and biotech organizations, today announced that it has successfully completed the acquisition of HHI Clinical & Statistical Research Services, L.L.C.
buyer: Ventiv Health
inVentiv Health, Inc. is the leading provider of commercialization and complementary services to the global pharmaceutical, life sciences and biotechnology industries. inVentiv delivers its customized clinical, sales, marketing and communications solutions. "
target: HHI Clinical Research & Statistical Services, L.L.C.
HHI Clinical Research & Statistical Services, L.L.C. is a focused clinical service provider managing statistical analysis and data management functions for pharmaceutical and biotechnology companies. HHI's services include data support, programming, statistical analysis and report writing. HHI has
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 9/25/2017 via BusinessWire

Konica Minolta, Inc., will acquire Invicro, LLC

synopsis: Konica Minolta, Inc. and Boston-based Invicro LLC announced that they have concluded an agreement whereby Konica Minolta will acquire Invicro, a leading provider of imaging services and software for research and drug development.
buyer: Konica Minolta, Inc. (TSE:4902:$8,793.96)
Konica Minolta, Inc. is a Japanese technology company headquartered in Tokyo. The company manufactures business and industrial imaging products, including copiers, laser printers, multi-functional peripherals (MFPs) and digital print systems for the production printing market. "
target: Invicro, LLC
Invicro is a leading provider of imaging services and software for research and drug development. Headquartered in Boston, Massachusetts, Invicro LLC was founded in 2008 with the mission of improving the role and function of imaging in drug discovery and development across all therapeutic areas.
price ($mm)
rev ($mm)
$106
EBITDA ($mm)
$17
EV / rev
0.0x
EV / EBITDA
0.0x
closed 8/16/2017 via BusinessWire

Evotec BioSystems GmbH, acquired Aptuit, Inc.

synopsis: Evotec announced that it has successfully completed the acquisition of Aptuit, a partner research organisation for integrated outsourced drug discovery and development solutions. This acquisition adds considerable business opportunities to further accelerate Evotec's long-term strategy to be the industry partner of choice for external innovation.
buyer: Evotec BioSystems GmbH (XTRA:EVT:$226.46)
Founded in Hamburg Germany, Evotec BioSystems GmbH is a drug discovery alliance and development partnership company focused on rapidly progressing innovative product approaches with leading pharmaceutical and biotechnology companies, academics, patient advocacy groups and venture capitalists. "
target parent: Welsh, Carson, Anderson & Stowe
target: Aptuit, Inc.
Aptuit, Inc. (formerly Global Pharmaceutical Development, Inc.) is an emerging company focused on streamlining and supporting the drug development process for biotechnology and pharmaceutical innovators.
price ($mm)
$300
rev ($mm)
$93
EBITDA ($mm)
$12
EV / rev
3.2x
EV / EBITDA
25.8x
announced 6/20/2017 via Company Press Release

Pamplona Capital Management LLP, will acquire PAREXEL International Corporation

synopsis: Pamplona Capital Management, LLP has entered into a definitive agreement to acquire all of the outstanding shares of PAREXEL International Corporation, a leading global biopharmaceutical services provider. PAREXEL provides a broad range of expertise-based clinical research, consulting, medical communications, and technology solutions and services.
buyer: Pamplona Capital Management LLP
Pamplona Capital Management is a London, New York, and Boston-based specialist investment manager established in 2005 that provides an alternative investment platform across private equity, fund of hedge funds, and single-manager hedge fund investments. "
target: PAREXEL International Corporation (PRXL:$1,939.36)
PAREXEL International Corporation is a leading global biopharmaceutical services company, providing a broad range of clinical research, consulting, medical communications, and technology solutions and services to the worldwide pharmaceutical, biotechnology and medical device industries.
price ($mm)[EV]
$4,508 [$4,923]
rev ($mm)
$2,097
EBITDA ($mm)
$343
EV / rev
2.4x
EV / EBITDA
14.6x
announced 5/10/2017 via BNC Analysis

inVentiv Health, Inc. will be merged with INC Research, Inc.,

synopsis: INC Research Holdings, Inc., a leading global Phase I-IV Contract Research Organization ("CRO"), and inVentiv Health, Inc., a leading, global CRO and Contract Commercial Organization will merge. INC Research shareholders will own approximately 53 percent and inVentiv shareholders will own approximately 47 percent of the merged entity.
buyer: INC Research, Inc. (INCR:$4,730.38)
INC Research is a leading global contract research organization ("CRO") providing the full range of Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. "
target parent: Thomas H. Lee Partners, L.P.
target: inVentiv Health, Inc.
inVentiv Health is a global professional services organization designed to help the biopharmaceutical industry accelerate the delivery of much-needed therapies to market. Their Clinical Research Organization (CRO) and Contract Commercial Organization (CCO) offer a differentiated suite of services.
price ($mm)[EV]
$2,453 [$4,552]
rev ($mm)
$2,156
EBITDA ($mm)
$306
EV / rev
2.1x
EV / EBITDA
14.9x
closed 10/3/2016 via BusinessWire

Quintiles Transnational Corp. merged with IMS Health Incorporated,

synopsis: Quintiles IMS Holdings, Inc. announced that it has successfully completed its merger of equals transaction between IMS Health Holdings, Inc. and Quintiles Transnational Holdings Inc. The merger creates a leading information and tech-enabled global healthcare service provider, and a full suite of end-to-end clinical and commercial offerings.
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is a leading global information and technology services company providing clients in the healthcare industry with end-to-end solutions to measure and improve their performance. They connect configurable SaaS applications to complex healthcare data in the IMS One™ cloud platform. "
target: Quintiles Transnational Corp. (Q:$4,497.17)
Quintiles is the world’s largest provider of biopharmaceutical development services and commercial outsourcing services. They help customers navigate the increasingly complex healthcare environment to improve efficiency and to deliver better healthcare outcomes.
price ($mm)
$8,750
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/6/2009 via BusinessWire

PPD, Inc., acquired Excel PharmaStudies Inc.

synopsis: PPD, Inc. announced it has completed its acquisition of Excel PharmaStudies, Inc., one of the largest contract research organizations in China. The acquisition strengthens PPD’s full range of drug development services in the country and positions it to capitalize on the tremendous growth of the outsourcing market in Asia Pacific.
buyer: PPD, Inc.
PPD is a leading global contract research organization (CRO) providing discovery, development and post-approval services as well as compound partnering programs. PPD's clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. "
target: Excel PharmaStudies Inc.
Excel PharmaStudies, Inc. is a full-service provider of clinical research, registration, biometrics, and training and consultation services. Excel is the leading CRO in China and operates 22 offices worldwide, with more than 300 staff members.
price ($mm)
$16
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/17/2009 via PR Newswire

Pierrel SpA, purchased US Operations from Encorium Group Inc.

synopsis: Encorium Group, Inc., a full service multinational clinical research organization, announced that is has completed the previously announced sale of the Company's U.S. business to Pierrel Research USA, Inc., a wholly-owned subsidiary of Pierrel SpA, an international contract research organization listed on Milano's Stock Exchange.
buyer: Pierrel SpA (PIELF:$0.00)
Pierrel S.p.A. is a pharmaceutical company specializing in contract research, development and the manufacture of medicines. The Pierrel Group boasts over 50 years of experience in the pharmaceutical sector, and is one of the main Italian manufacturers of local anaesthetics for dental use. "
seller: Encorium Group Inc.
Encorium is a full-service Contract Research Organization providing comprehensive solutions for pharmaceutical, biotechnology, and medical device companies. At Encorium we recognize the challenges that often arise during drug development.
price ($mm)[EV]
$0.08 [$2.58]
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 4/8/2009 via PR Newswire

Next Fuel, Inc., will acquire Clinical Trials of the Americas, Inc.

synopsis: Clinical Trials of America Inc. announced that it has entered into a binding letter of intent to sell shares equal to approximately 75% of its issued and outstanding shares to Next Fuel Inc., a developer of a proprietary "On Demand" Hydrogen Generation System.
buyer: Next Fuel, Inc.
Next Fuel Inc. is a developer of a proprietary "On Demand" Hydrogen Generation System that is used as fuel for Fuel Cells which produce electricity. "
target: Clinical Trials of the Americas, Inc.
Clinical Trials of the Americas, Inc. provides clinical trial investigator services in dedicated sites throughout the Americas. Initially, we intend to introduce our services in Central America.
price ($mm)
$0.29*
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/2/2009 via PR Newswire

ASG, Inc., acquired Ockham Development Group, Inc.

synopsis: ASG, Inc. a high-quality functional outsourcing and specialty staffing services group based in Cary, North Carolina - has acquired neighboring Ockham Development Group, Inc., a full-service contract research organization.
buyer: ASG, Inc.
ASG provides high-quality functional outsourcing and specialty staffing services to CROs, pharmaceutical, biotech and medical device companies that require clinical operations, GCP, GLP or GMP auditing, data management, statistical programming, biostatistics and medical writing solutions. "
target: Ockham Development Group, Inc.
Ockham Development Group Inc. is a privately held contract research organization headquartered in Cary, North Carolina.
price ($mm)
rev ($mm)
$12
EBITDA ($mm)
EV / rev
0.0x
EV / EBITDA
closed 4/22/2009 via BusinessWire

PPD, Inc., acquired AbCRO, Inc.

synopsis: PPD, Inc. announced that it has completed the acquisition of AbC.R.O., Inc., a Bulgarian contract research organization. The acquisition strengthens PPD’s ability to provide a broad range of clinical trial management and monitoring, patient recruitment, site identification and regulatory affairs services to its growing client base in the Balkans.
buyer: PPD, Inc.
PPD is a leading global contract research organization (CRO) providing discovery, development and post-approval services as well as compound partnering programs. PPD's clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. "
target: AbCRO, Inc.
AbCRO provides a full range of Phase II-IV clinical services, including clinical trial management and monitoring, patient recruitment, site identification and regulatory affairs.
price ($mm)
$36
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/20/2009 via PR Newswire

PharmaNet Development Group, Inc. merged with JLL Partners,

synopsis: JLL Partners, a leading private equity investment fund, and PharmaNet Development Group, Inc., a leading provider of clinical development services, announced the successful completion of the tender offer by JLL PharmaNet Holdings, LLC.
buyer: JLL Partners
Founded in 1988, JLL Partners is among the leading private equity investment firms in the country. Since inception, we have managed a series of private equity funds aggregating approximately $4 billion in committed capital. "
target: PharmaNet Development Group, Inc.
PharmaNet Development Group, Inc. is a leader in outsourced clinical development that offers clinical-development solutions including early and late stage consulting services, Phase I clinical studies and bioanalytical analyses, and Phase II, III and IV clinical development programs.
price ($mm)[EV]
$101 [$186]
rev ($mm)
$451
EBITDA ($mm)
$26
EV / rev
0.4x
EV / EBITDA
7.1x
closed 1/27/2009 via BusinessWire

Altarum Institute, acquired KAI Research, Inc.

synopsis: Altarum Institute, a non-profit health systems research and consulting organization, has purchased Rockville, Maryland-based KAI Research, Inc. (KAI). KAI provides innovative, cost-effective and practical support to the pharmaceutical and biotech industry, academic institutions and the National Institutes of Health.
buyer: Altarum Institute
Altarum Institute is a nonprofit health systems research and consulting organization serving government and private-sector clients. "
target: KAI Research, Inc.
KAI Research provides innovative, cost-effective and practical support to the pharmaceutical and biotech industries. KAI currently supports pharmaco-vigilance activities for over 90 marketed drugs and is providing safety surveillance for dozens of ongoing clinical trials.
price ($mm)
$7.55
rev ($mm)
$10
EBITDA ($mm)
EV / rev
0.8x
EV / EBITDA
closed 3/13/2009 via BNC Analysis

Premier Research Group, acquired Pivotal Research Centers, LLC

synopsis: PHC, Inc. d/b/a Pioneer Behavioral Health, a leading provider of inpatient and outpatient behavioral health services, announced Premier Research Arizona, LLC, a unit of Premier Research Group PLC, has signed a purchase agreement to acquire the assets of PHC's Pivotal Research Centers.
buyer: Premier Research Group
Premier Research is a leading solutions-driven CRO committed to therapeutic focus and operational expertise to deliver clinical trial services of the highest quality for biopharmaceutical and medical device companies. "
target parent: Pioneer Behavioral Health
target: Pivotal Research Centers, LLC
Pivotal Research Centers, LLC provides clinical drug testing. It performs all phases of clinical research for Phase I to Phase IV drugs under development through two research sites. Pivotal was founded by Louis C. Kirby in 1993 and is based in Phoenix, Arizona.
price ($mm)
$3.00
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/30/2007 via Company Press Release

Chiltern International Inc., acquired Clinical Trial Management Services, Inc.

synopsis: Chiltern, a leading global clinical research organization (CRO), announced the acquisition of Clinical Trial Management Services, Inc. (CTMS) a Bristol, Tennessee based CRO offering high quality services throughout the United States.
buyer: Chiltern International Inc.
Chiltern is a global CRO with experience running and staffing international Phase I to Phase IV clinical trials. Chiltern’s services include: Early Phase, Global Clinical Development, Late Phase, Biometrics, Medical and Regulatory Affairs and Resourcing Solutions. "
target: Clinical Trial Management Services, Inc.
Clinical Trial Management Services, Inc. provides clinical research services such as clinical trial management and monitoring services, such as project management, investigative site management and monitoring services.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/14/2009 via BusinessWire

NexMed, Inc., acquired Bio-Quant, Inc.

synopsis: NexMed, Inc., a developer of products based on the NexACT® technology, announced the closing of its acquisition of Bio-Quant, Inc., a privately-held leading research organization for in vitro and in vivo contract drug discovery and pre-clinical development services, headquartered in San Diego, CA.
buyer: NexMed, Inc. (NEXM:$0.00)
NexMed is an innovative drug developer that is leveraging its proprietary NexACT® drug delivery technology to produce a host of new medical treatments. NexMed’s drugs address a variety of health conditions, such as nail fungus, sexual disorders and more. "
target: Bio-Quant, Inc.
Founded in 1999, Bio-Quant is the largest specialty CRO based in San Diego and is one of the industry's most experienced CROs for in vitro and in vivo pharmacology services and research models specializing in oncology, inflammation, immunology, and metabolic diseases, including diabetes.
price ($mm)[EV]
$13 [$13]
rev ($mm)
$5
EBITDA ($mm)
EV / rev
2.5x
EV / EBITDA
announced 10/28/2009 via PR Newswire

Alpha Analytical, will acquire Boston Analytical

synopsis: Alpha Analytical is announcing the completion of the acquisition of Boston Analytical, Inc. Established in 1987, Boston Analytical is a registered, cGMP compliant contract testing laboratory providing quality analytical and microbiological testing services to the pharmaceutical, biotech, device, cosmetic and nutritional product industries.
buyer: Alpha Analytical
Alpha Analytical, Inc. provides full-service environmental laboratory solutions for the most demanding industrial and commercial applications in the U.S. and abroad. Alpha Analytical is the largest environmental laboratory in New England and among the top 18 laboratories in the country. "
target: Boston Analytical
Boston Analytical is committed to providing quality Analytical and Microbiological testing services to pharmaceutical companies worldwide in support of their Product Development, Release and Stability Testing objectives.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/12/2009 via Company Press Release

J O Hambro Capital Management Limited, acquired Celsis International

synopsis: Chicago-based Celsis International, a leading global life sciences company, announces that it has been acquired by UK-based private equity firm J O Hambro and will de-list from the London Stock Exchange (LSE) and operate as a privately held company.
buyer: J O Hambro Capital Management Limited
J O Hambro Capital Management, the London-based boutique investment firm, offers an alternative to the large traditional fund management firms that have dominated the market for many years. "
target: Celsis International
Celsis International plc is a leading international provider of innovative life science products and laboratory services to the pharmaceutical and consumer products industries through our three divisions: Rapid Detection, Analytical Services and In Vitro Technologies.
price ($mm)[EV]
$55 [$52]*
rev ($mm)
$42
EBITDA ($mm)
$12
EV / rev
1.9x
EV / EBITDA
6.3x
closed 7/16/2009 via PR Newswire

Water Street Healthcare Partners, acquired AAIPharma Services

synopsis: Water Street Healthcare Partners, a leading private equity firm focused exclusively on the health care industry, announced that it has acquired the Pharmaceutical Development division from AAIPharma Inc.
buyer: Water Street Healthcare Partners
Water Street Healthcare Partners is a leading private equity firm focused exclusively on health care. With more than $1 billion of capital under management, Water Street is one of the most active investors in the health care industry. "
target parent: AAIPharma Inc.
target: AAIPharma Services
AAIPharma Services serves more than 300 large pharmaceutical and biotechnology companies. Its team of 450 scientists and professionals specialize in services that encompass the entire process of pharmaceutical drug development from discovery through commercialization.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 6/1/2009 via Reuters

INC Research, Inc., will purchase Late Stage Research Unit from MDS, Inc.

synopsis: MDS Inc has announced that it planns to narrow its contract research focus by selling its late stage operations and central laboratory divisions to Contract Research Organization INC Research, Inc.
buyer: INC Research, Inc. (INCR:$4,730.38)
INC Research is a therapeutically focused contract research organization with an unrivaled reputation for conducting Phase I- Phase IV clinical development programs of the highest integrity. "
seller: MDS, Inc. (MDZ:$231.00)
MDS Inc. is a global life sciences company that provides market-leading products and services that are used by its customers for the development of drugs, and the diagnosis and treatment of disease. The Company has more than 5,000 employees in 29 countries and net revenues of more than US$1.2 bil.
price ($mm)
$45
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/17/2009 via PR Newswire

ChemRar High-Tech Center, acquired Prudentas, LLC

synopsis: ChemDiv, a global chemistry-driven contract research organization, announced that its ChemRar High Tech Center has acquired Prudentas LLC, one of the leading CRO companies conducting high quality Phase I - Phase IV studies in Eastern Europe.
buyer parent: ChemDiv, Inc.
buyer: ChemRar High-Tech Center
The ChemRar High-Tech Center is a unique pharma and biotechnology complex founded by innovative life science organizations in Russia. ChemRar's component companies are engaged in discovering, developing and commercializing novel drugs for partners in Russia and worldwide. "
target: Prudentas, LLC
Prudentas is a Russian Clinical Contract Research Organization founded by and consisting of highly qualified clinical research professionals with extensive experience of working previously together as a team.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA

Like Adheris, Inc.


read more

Adheris, Inc.

GuildLink

MarkeTouch Media, Inc.

OmniSYS, LLC

Transaction Data Systems

Smith Technologies

Mirixa Corporation

Kroll Computer Systems Inc.

Ateb, Inc.

Computer-Rx

farma3tec S.r.l.

Artefact Informatique, Inc.

Regent Healthcare Systems, Inc

Hann's On Software

JASCORP

FarmaTools

Ample Organics Inc.

Clinical Support Services

CareMeds Ltd

MMJMenu, LLC

read more

Catalina Marketing Corporation

Adheris, Inc.

read more

inVentiv Health, Inc.

Catalina Marketing Corporation

MySTRO

Kazaam Interactive

Kforce Clinical Research, Inc.

Star Terre Santé

inVentiv Health, Inc.

Innovative Health Strategies, Inc.

Addison Whitney

Ignite Health

Maxwell Group Inc.

American Speaker Education Research and Training, LLC

Synergos, Inc.

Jeffrey Simbrow Associates

Adheris, Inc.

Inchord Communications, Inc.

HHI Clinical Research & Statistical Services, L.L.C.

read more

Invicro, LLC

Aptuit, Inc.

PAREXEL International Corporation

inVentiv Health, Inc.

Quintiles Transnational Corp.

Excel PharmaStudies Inc.

Encorium Group Inc.

Clinical Trials of the Americas, Inc.

Ockham Development Group, Inc.

AbCRO, Inc.

PharmaNet Development Group, Inc.

KAI Research, Inc.

Pivotal Research Centers, LLC

Clinical Trial Management Services, Inc.

Bio-Quant, Inc.

Boston Analytical

Celsis International

AAIPharma Services

MDS, Inc.

Prudentas, LLC

Geography
Matching Companies
Ticker: ASX:MDR
 
 
 
 
 
 
 
 
MedAdvisor Limited
MedAdvisor Limited
MedAdvisor is a world class medication management platform focused on addressing the gap and burden of medication adherence. The highly automated Australian software system connects patients to their local pharmacy, providing them with real time access to their personal medication records.
year
2021
rev ($mm)
$26.91
EBITDA ($mm)
($10.89)
EBIT ($mm)
($11.69)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: ZMD
 
 
 
 
 
 
 
 
ZoomMed Inc.
ZoomMed Inc.
Zoommed Inc. develops and markets various computer applications for healthcare professionals in Canada. The company builds and operates the ZoomMed Communication Network, a clinical interoperable information exchange network between physicians and various other stakeholders of the healthcare sector.
year
2014
rev ($mm)
$6.08
EBITDA ($mm)
$2.65
EBIT ($mm)
$2.78
Net Income ($mm)
Employees
40
  • drill down
  • watch
Ticker: KERN
 
 
 
 
 
 
 
 
Akerna
Akerna
Akerna is an enterprise software company focused on compliantly serving the cannabis, hemp, and CBD industries. Using connected data and information to propel the cannabis industry forward, Akerna empowers businesses, governments, patients, and consumers to make smart decisions.
year
2020
rev ($mm)
$13.09
EBITDA ($mm)
($19.19)
EBIT ($mm)
($20.36)
Net Income ($mm)
Employees
136
  • drill down
  • watch
Ticker: OTCPK:MJTK
 
 
 
 
 
 
 
 
CannaSys, Inc.
CannaSys, Inc.
CannaSys is a leading technology solutions, marketing and branding company in the regulated cannabis industry. Its products are delivered SaaS to facilitate point-of-purchase transactions, customer relationship marketing solutions and regulated cannabis laboratory information management systems.
year
2017
rev ($mm)
$0.01
EBITDA ($mm)
($1.09)
EBIT ($mm)
($1.07)
Net Income ($mm)
Employees
2
  • drill down
  • watch
Ticker: QSII
 
 
 
 
 
 
 
 
Quality Systems, Inc.
Quality Systems, Inc.
Quality Systems, Inc. and its NextGen Healthcare subsidiary develop and market computer-based practice management, electronic health records and revenue cycle management applications as well as connectivity products and services for medical and dental group practices.
year
2015
rev ($mm)
$499.35
EBITDA ($mm)
$57.19
EBIT ($mm)
$44.23
Net Income ($mm)
$32.10
Employees
2927
  • drill down
  • watch
Ticker: ENXTLS:GLINT
 
 
 
 
 
 
 
 
Glintt
Glintt
Glintt is a leading consulting and technological services company based in Portugal. Glintt develops products for hospitals, clinics and pharmacies. They support their clients in their digital transformation and offers software solutions that helps them to run their business more efficiently.
year
2021
rev ($mm)
$108.88
EBITDA ($mm)
$8.80
EBIT ($mm)
$7.81
Net Income ($mm)
$1.63
Employees
1084
  • drill down
  • watch
Ticker: TSXV:PHA
 
 
 
 
 
 
 
 
Premier Health of America Inc.
Premier Health of America Inc.
Premier Health of America is a Canadian Healthtech company that provides a comprehensive range of staffing and outsourced services solutions. Premier Health uses its PSweb platform to lead the healthcare services sector digital transformation to provide patients more accessible care services.
year
2020
rev ($mm)
$24.62
EBITDA ($mm)
$2.53
EBIT ($mm)
$2.36
Net Income ($mm)
$0.49
Employees
0
  • drill down
  • watch
Ticker: OB:NORDH
 
 
 
 
 
 
 
 
Nordhealth AS
Nordhealth AS
Nordhealth AS is a provider of cloud-based Practice Management Software (PMS). Nordhealth is a pioneer and global leader in providing SaaS-solutions for healthcare practitioners, helping healthcare practitioners, improve care, save time and grow their business.
year
2021
rev ($mm)
$22.23
EBITDA ($mm)
($0.24)
EBIT ($mm)
($4.88)
Net Income ($mm)
Employees
300
  • drill down
  • watch
Ticker: OTCPK:VMCI
 
 
 
 
 
 
 
 
iCoreConnect Inc.
iCoreConnect creates communication and practice management software that allows users to share information at the highest levels of security, and they back it up with real customer service.
year
2021
rev ($mm)
$2.83
EBITDA ($mm)
($2.82)
EBIT ($mm)
($2.85)
Net Income ($mm)
Employees
25
  • drill down
  • watch
Ticker: OMCL
 
 
 
 
 
 
 
 
Omnicell, Inc.
Omnicell, Inc.
Omnicell is a leading supplier of comprehensive automation and business analytics software for patient-centric medication and supply management across the entire health care continuum—from the acute care hospital setting to post-acute skilled nursing and long-term care facilities to the home.
year
2021
rev ($mm)
$914.37
EBITDA ($mm)
$99.36
EBIT ($mm)
$57.86
Net Income ($mm)
$35.01
Employees
2970
  • drill down
  • watch
Ticker: TRHC
 
 
 
 
 
 
 
 
Tabula Rasa Healthcare
Tabula Rasa Healthcare
Tabula Rasa HealthCare (TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk.
year
2022
rev ($mm)
$339.59
EBITDA ($mm)
($27.37)
EBIT ($mm)
($76.52)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: ASX:CGL
 
 
 
 
 
 
 
 
Citadel Group Limited
Citadel Group Limited
Citadel is a leading Australian technology and software company that specialise in secure enterprise information management in complex environments. Citadel provides secure information to support real-time decisions across the Health, National Security and Defence industries.
year
2019
rev ($mm)
$73.75
EBITDA ($mm)
$10.86
EBIT ($mm)
$8.04
Net Income ($mm)
$4.10
Employees
180
  • drill down
  • watch
Ticker: MTBC
 
 
 
 
 
 
 
 
Medical Transcription Billing, Corp.
Medical Transcription Billing, Corp.
MTBC (Medical Transcription Billing, Corp) is a healthcare information technology company that provides a fully integrated suite of proprietary web-based solutions, together with related business services, to healthcare providers, revenue cycle management companies and software vendors.
year
2019
rev ($mm)
$65.19
EBITDA ($mm)
$1.78
EBIT ($mm)
($1.62)
Net Income ($mm)
Employees
2400
  • drill down
  • watch
Ticker: CRW.L
 
 
 
 
 
 
 
 
Craneware, Inc.
Craneware, Inc.
Craneware, based in Scotland, is the leader in automated revenue integrity solutions that improve financial performance for healthcare organizations. Its SaaS solutions help and healthcare providers effectively price, charge, and code for services and supplies associated with patient care.
year
2012
rev ($mm)
$42.44
EBITDA ($mm)
$12.06
EBIT ($mm)
$10.80
Net Income ($mm)
$9.43
Employees
  • drill down
  • watch
Ticker: QHR
 
 
 
 
 
 
 
 
QHR Technologies Inc.
QHR Technologies Inc.
QHR is a leader in Healthcare Technology, empowering providers and connecting patients. With an 11-year track record offering what is now the single leading Electronic Medical Records in Canada, QHR has a suite of complementary offerings that empower health professionals.
year
2016
rev ($mm)
$23.60
EBITDA ($mm)
$2.08
EBIT ($mm)
$0.83
Net Income ($mm)
$0.09
Employees
200
  • drill down
  • watch
Ticker: INCR
 
 
 
 
 
 
 
 
Syneos Health
Syneos Health
Syneos Health is the only fully integrated biopharmaceutical solutions organization. Their company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities.
year
2021
rev ($mm)
$4,730.38
EBITDA ($mm)
$633.74
EBIT ($mm)
$407.86
Net Income ($mm)
$235.93
Employees
24310
  • drill down
  • watch
Ticker: ICLR
 
 
 
 
 
 
 
 
ICON Plc
ICON Plc
ICON plc is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company specialises in the strategic development, management and analysis of programs that support clinical development.
year
2015
rev ($mm)
$1,541.91
EBITDA ($mm)
$289.74
EBIT ($mm)
$234.82
Net Income ($mm)
$192.14
Employees
11200
  • drill down
  • watch
Ticker:
 
 
 
 
 
 
 
 
CMIC Co., Ltd.
CMIC is a leading full-service CRO in Japan offering a wide range of services in clinical trials in Asia to both multi-national and Japanese pharma companies.
year
2019
rev ($mm)
$664.65
EBITDA ($mm)
$76.21
EBIT ($mm)
$43.15
Net Income ($mm)
$23.12
Employees
4962
  • drill down
  • watch
Ticker: PIELF
 
 
 
 
 
 
 
 
Pierrel SpA
Pierrel SpA
Pierrel S.p.A. is a pharmaceutical company specializing in contract research, development and the manufacture of medicines. The Pierrel Group boasts over 50 years of experience in the pharmaceutical sector, and is one of the main Italian manufacturers of local anaesthetics for dental use.
year
2008
rev ($mm)
$64.38
EBITDA ($mm)
($4.23)
EBIT ($mm)
($8.92)
Net Income ($mm)
Employees
504
  • drill down
  • watch
Ticker: ENCO
 
 
 
 
 
 
 
 
Encorium Group Inc.
Encorium is a full-service Contract Research Organization providing comprehensive solutions for pharmaceutical, biotechnology, and medical device companies. At Encorium we recognize the challenges that often arise during drug development.
year
2008
rev ($mm)
$35.91
EBITDA ($mm)
($5.19)
EBIT ($mm)
($6.89)
Net Income ($mm)
Employees
226
  • drill down
  • watch
Ticker: TSXV:IPA
 
 
 
 
 
 
 
 
ImmunoPrecise
ImmunoPrecise
ImmunoPrecise Antibodies (IPA) is a full-service, therapeutic antibody discovery company offering species agnostic advancements such as the B cell Select™ single-cell interrogation technology, DeepDisplay™ custom phage libraries, as well as the Abthena™.
year
2021
rev ($mm)
$14.38
EBITDA ($mm)
($3.69)
EBIT ($mm)
($5.34)
Net Income ($mm)
Employees
73
  • drill down
  • watch
Ticker: ENXTPA:ERF
 
 
 
 
 
 
 
 
Eurofins Group
Eurofins Group
Based in Luxembourg, Eurofins is a leading international group of laboratories providing a unique range of analytical testing services to the pharmaceutical, food, environmental and consumer products industries and to governments.
year
2019
rev ($mm)
$5,244.00
EBITDA ($mm)
$922.65
EBIT ($mm)
$524.54
Net Income ($mm)
$224.34
Employees
47427
  • drill down
  • watch
Ticker: CRL
 
 
 
 
 
 
 
 
Charles River Laboratories International Inc.
Charles River Laboratories International Inc.
Charles River has been helping our global partners accelerate drug discovery and development by providing them with tailored research models and preclinical, clinical, support services.
year
2009
rev ($mm)
$1,202.55
EBITDA ($mm)
$282.48
EBIT ($mm)
$188.93
Net Income ($mm)
$114.44
Employees
8000
  • drill down
  • watch
Ticker: NEO
 
 
 
 
 
 
 
 
NeoGenomics Laboratories
NeoGenomics Laboratories
NeoGenomics is a leading cancer diagnostic reference laboratory. NeoGenomics offers testing services for oncologists, pathologists, and pharmaceutical centers. Their areas of expertise include cancer cytogenetics, hematologic and solid tumor FISH testing, molecular oncology tests, and more.
year
2020
rev ($mm)
$444.45
EBITDA ($mm)
$23.80
EBIT ($mm)
($11.92)
Net Income ($mm)
$4.17
Employees
1700
  • drill down
  • watch
Ticker: LH
 
 
 
 
 
 
 
 
LabCorp
LabCorp provides leading-edge medical laboratory tests and services through a national network of primary clinical laboratories and specialty testing laboratories. LabCorp processes tests on approximately 470,000 specimens each day, applying advances in medicine and science to laboratory testing.
year
2021
rev ($mm)
$16,388.10
EBITDA ($mm)
$4,886.00
EBIT ($mm)
$4,358.30
Net Income ($mm)
$2,878.70
Employees
68780
  • drill down
  • watch